Real-World Outcomes for Patients With CLL Differ in Community Setting
The Connect CLL Registry revealed that real-world treatment outcomes for patients with CLL who were treated in the community setting differed from trial results.
All articles by Christina Bennett, MS
FLAG+/-Ida Linked to Better Outcomes in Non-Favorable–Risk AML
Induction regimen FLAG+/-Ida appears to be more effective than 7+3 in patients with non-favorable risk AML, but prospective data are needed.
Second Hematologic Malignancy Deemed a “Rare” Event in CLL
The development of a second hematologic malignancy after being diagnosed with chronic lymphocytic leukemia (CLL) appears to be uncommon, a retrospective study found.
Study Calls for Unified Grading System for CAR-T Toxicities
A study found that grading systems for assessing toxicities from CAR-T therapy produced inconsistent scores, prompting a call for a more unified grading approach.
Clinical Response to Tisagenlecleucel Confers HRQoL Benefit in Lymphoma
Patients with relapsed/refractory diffuse large B-cell lymphoma who responded to tisagenlecleucel also had improved health-related quality of life outcomes.
Study Supports Less Frequent Dosing of Bortezomib in Multiple Myeloma
For patients with newly diagnosed multiple myeloma, a less frequent dosing regimen of bortezomib may elicit a similar clinical response.
Machine Learning Identifies Newly Diagnosed CLL Patients at Risk for Certain Outcomes
Machine learning may help identify newly diagnosed patients with CLL who are at risk for infection or treatment within 2 years of a diagnosis.
Study Finds Real-World Outcomes Differ for Idelalisib in FL and CLL
The analysis revealed that Medicare beneficiaries had different treatment outcomes compared with the trial participants.
Circulating Tumor Plasma Cells Predict Progression in Myeloma
The presence of circulating tumor plasma cells by next-generation flow independently predicted disease progression after treatment in patients with multiple myeloma.
Older Patients With Follicular Lymphoma Benefit From Appropriate Therapy
For older patients with follicular lymphoma, receipt of appropriate therapy for this disease was associated with a significant gain in overall survival.
Next post in Lymphoma
